TPP1 and cancer: Many POT1 mutants that result in the loss of DNA-binding capacity but retain TPP1 binding may lead to an increase of telomere length in cells that have telomerase activity and correspondingly many rare functional variants in POT1 have been associated with cancer risks and longer but more fragile telomeres that promote genomic instability30–33.